fda semaglutide compounding enforcement november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA is moving to restrict
Description
Measure things like waist circumference, body fat percentage, strength, and not just what the scale says
Ozempic (semaglutide) is a GLP-1 receptor agonist used to treat Type 2 diabetes, but with its list price exceeding $1,300 per pen, insurance coverage matters

Some patients report feeling tired or having reduced energy levels, which may be related to changes in eating patterns or the direct effects of the medication on metabolism

Follow up & Optimization After your first 30 days of treatment we mail you a follow-up at-home lab test to capture your testosterone improvements

(82) provide tangible evidence that alpha-cells can be converted to functional beta-cells in response to beta-cell dysfunction

Chew Gum After Meals Chewing gum stimulates saliva production
